Tango Therapeutics, Inc. - Common Stock, par value $0.001 per share (TNGX)

CUSIP: 87583X109

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
143,181,938
Total 13F shares
68,157,717
Share change
-2,311,660
Total reported value
$246,729,459
Price per share
$3.62
Number of holders
86
Value change
-$12,119,590
Number of buys
41
Number of sells
28

Security key

87583X109

Report period

Q3 2022

Institutions

86

Top holders

10

Top shareholders of TNGX - Tango Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
TRV GP IV, LLC
13F
Company
14%
19,363,975
$87,719,000 30 Jun 2022
13F
FMR LLC
13F
Company
5.3%
7,631,917
$34,572,000 30 Jun 2022
13F
Boxer Capital, LLC
13F
Company
4.8%
6,871,642
$31,129,000 30 Jun 2022
13F
Cormorant Asset Management, LP
13F
Company
3.1%
4,507,843
$20,421,000 30 Jun 2022
13F
Southpoint Capital Advisors LP
13F
Company
3.1%
4,500,000
$20,385,000 30 Jun 2022
13F
Casdin Capital, LLC
13F
Company
2.4%
3,500,000
$15,855,000 30 Jun 2022
13F
BlackRock Finance, Inc.
13F
Company
2.2%
3,160,387
$14,316,000 30 Jun 2022
13F
VANGUARD GROUP INC
13F
Company
2.1%
3,011,918
$13,644,000 30 Jun 2022
13F
EcoR1 Capital, LLC
13F
Company
1.6%
2,302,065
$10,428,000 30 Jun 2022
13F
Bain Capital Life Sciences Investors, LLC
13F
Company
1.3%
1,921,790
$8,706,000 30 Jun 2022
13F
Avoro Capital Advisors LLC
13F
Company
1.1%
1,550,000
$7,022,000 30 Jun 2022
13F
TCG Crossover Management, LLC
13F
Company
0.82%
1,172,250
$5,310,000 30 Jun 2022
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
0.7%
1,000,000
$4,530,000 30 Jun 2022
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.69%
990,500
$4,486,000 30 Jun 2022
13F
Avidity Partners Management LP
13F
Company
0.57%
813,640
$3,686,000 30 Jun 2022
13F
BAKER BROS. ADVISORS LP
13F
Company
0.52%
750,000
$3,398,000 30 Jun 2022
13F
STATE STREET CORP
13F
Company
0.52%
742,336
$3,363,000 30 Jun 2022
13F
HARVARD MANAGEMENT CO INC
13F
Company
0.49%
708,385
$3,209,000 30 Jun 2022
13F
BESSEMER GROUP INC
13F
Company
0.49%
708,384
$3,209,000 30 Jun 2022
13F
Samsara BioCapital, LLC
13F
Company
0.44%
630,000
$2,854,000 30 Jun 2022
13F
Woodline Partners LP
13F
Company
0.35%
500,095
$2,265,000 30 Jun 2022
13F
TANG CAPITAL MANAGEMENT LLC
13F
Company
0.33%
468,750
$2,123,000 30 Jun 2022
13F
NORTHERN TRUST CORP
13F
Company
0.3%
435,574
$1,974,000 30 Jun 2022
13F
CITADEL ADVISORS LLC
13F
Company
0.29%
414,195
$1,876,000 30 Jun 2022
13F
FARALLON CAPITAL MANAGEMENT LLC
13F
Company
0.21%
300,000
$1,359,000 30 Jun 2022
13F
Ensign Peak Advisors, Inc
13F
Company
0.21%
299,391
$1,356,000 30 Jun 2022
13F
D. E. Shaw & Co., Inc.
13F
Company
0.12%
177,416
$804,000 30 Jun 2022
13F
Nuveen Asset Management, LLC
13F
Company
0.11%
163,334
$740,000 30 Jun 2022
13F
BARCLAYS PLC
13F
Company
0.1%
138,836
$629,000 30 Jun 2022
13F
Bank of New York Mellon Corp
13F
Company
0.09%
134,384
$608,000 30 Jun 2022
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.09%
131,552
$596,000 30 Jun 2022
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.09%
126,778
$575,000 30 Jun 2022
13F
Oasis Management Co Ltd.
13F
Company
0.08%
117,000
$530,000 30 Jun 2022
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.06%
80,444
$364,000 30 Jun 2022
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.06%
80,395
$364,000 30 Jun 2022
13F
Alyeska Investment Group, L.P.
13F
Company
0.05%
74,338
$337,000 30 Jun 2022
13F
Swiss National Bank
13F
Company
0.05%
72,300
$328,000 30 Jun 2022
13F
Cubist Systematic Strategies, LLC
13F
Company
0.05%
70,889
$321,000 30 Jun 2022
13F
RHUMBLINE ADVISERS
13F
Company
0.05%
65,934
$299,000 30 Jun 2022
13F
ALPS ADVISORS INC
13F
Company
0.04%
52,145
$236,000 30 Jun 2022
13F
BANK OF MONTREAL /CAN/
13F
Company
0.04%
51,992
$231,000 30 Jun 2022
13F
JPMORGAN CHASE & CO
13F
Company
0.03%
49,327
$224,000 30 Jun 2022
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.03%
46,009
$208,000 30 Jun 2022
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
0.03%
40,003
$181,000 30 Jun 2022
13F
Janney Montgomery Scott LLC
13F
Company
0.03%
40,000
$176,000 30 Jun 2022
13F
XTX Topco Ltd
13F
Company
0.02%
34,569
$157,000 30 Jun 2022
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.02%
33,100
$150,000 30 Jun 2022
13F
MetLife Investment Management, LLC
13F
Company
0.02%
28,639
$129,735 30 Jun 2022
13F
CREDIT SUISSE AG/
13F
Company
0.02%
27,437
$125,000 30 Jun 2022
13F
Aviva Holdings Ltd.
13F
Company
0.02%
26,961
$122,000 30 Jun 2022
13F

Institutional Holders of Tango Therapeutics, Inc. - Common Stock, par value $0.001 per share (TNGX) as of Q3 2022

As of 30 Sep 2022, Tango Therapeutics, Inc. - Common Stock, par value $0.001 per share (TNGX) was held by 86 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 68,157,717 shares. The largest 10 holders included TRV GP IV, LLC, FMR LLC, BOXER CAPITAL, LLC, Southpoint Capital Advisors LP, EcoR1 Capital, LLC, Cormorant Asset Management, LP, BlackRock Inc., VANGUARD GROUP INC, Bain Capital Life Sciences Investors, LLC, and Avoro Capital Advisors LLC. This page lists 86 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders
76
Q3 2022 holders
86
Holder diff
10
Investor Q2 2022 Shares Q3 2022 Shares Share Diff Share Chg % Q2 2022 Value $ Q3 2022 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .